NCT01421290

Brief Summary

The hypothesis of this study is to investigate whether surgical intervention is necessary for patients who suffer from cartilage lesions of the knee, or whether this surgical intervention can be avoided or postponed by using conservative treatment options such as physiotherapy, nutrition supplements, intra-articular injections, bracing. Forty patients suffering from cartilage lesions in their knee joint will be selected preoperatively. All these patients fulfil certain inclusion- and exclusion criteria. They will be asked to respond to 3 different questionnaires. These questionnaires include the visual analogue scale to evaluate pain (VAS), the Knee injury and Osteoarthritis Outcome Score or KOOS and the International Knee Documentation Committee (IKDC) form to evaluate the effect of their cartilage lesion on activities in daily life. Six months later +/- 20 patients will have had surgery and +/- 20 patients will have had conservative treatment, both groups of patients will be asked to respond again to the 3 different questionnaires. The outcome of the results will tell us more of the evolution both between groups and in each group separately.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 17, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 22, 2011

Completed
1.4 years until next milestone

Study Start

First participant enrolled

January 1, 2013

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

2.9 years

First QC Date

August 17, 2011

Last Update Submit

December 13, 2022

Conditions

Keywords

Cartilage lesions in the knee joint

Outcome Measures

Primary Outcomes (1)

  • Questionnaires to decide which intervention will be performed.

    The questionnaires include the visual analogue scale to evaluate pain (VAS), the Knee injury and Osteoarthritis Outcome Score or KOOS and the International Knee Documentation Committee subjective knee form (IKDC) to evaluate the effect of their cartilage lesion on activities in daily life

    At day 1

Secondary Outcomes (1)

  • Questionnaires to measure patient satisfaction.

    At 6 months

Study Arms (2)

Conservative treatment

ACTIVE COMPARATOR
Other: Conservative comparator

Surgery

ACTIVE COMPARATOR
Procedure: Surgery

Interventions

SurgeryPROCEDURE

Knee surgery

Surgery

Kinesitherapy, intra-articular injection, wearing a brace, thermotherapy, intake of supplements.

Conservative treatment

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Symptomatic single cartilage lesions of the femur condyles
  • Size of the lesion, determined by MRI:
  • between 1-2 cm² for the group who will receive conservative treatment between 2-5 cm² for the group who will have surgery
  • \- Mechanical joint pain, assessed by a 100 mm Visual Analogue Scale: \> 40 mm for the conservative group, \> 60 mm for the operative group
  • Agree to stop using analgetics and NSAID's 2 weeks before the First respond of the surveys, and 2 weeks before the second respond of the surveys. Only paracetamol (4g/day) is allowed.
  • men and women, women have to use contraceptive to avoid pregnancies.
  • age between 18 - 50 years

You may not qualify if:

  • participation in concurrent trials
  • participation in previous trials within 3 months
  • subjects with HIV, hepatitis, syphilis
  • malignancy
  • alcohol and drug abuse
  • poor general health condition as judged by the investigator
  • osteochondritis dissecans
  • advanced osteoarthritis (kellgren 2-4)
  • known allergy to penicillins and gentamicin or presence of multiple severe allergies
  • complex ligamentous instability of the knee
  • lateral meniscus lesion or more than 50% resection of medial meniscus
  • Varus or valgus misalignment exceeding 3° (kissing lesions out)
  • Mosaicplasty (OATS)
  • Microfracture performed less than 1 year before baseline
  • Received hyaluronic acid intra-articular injections into the afflicted knee within the last six months of baseline
  • +11 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Ghent

Ghent, Belgium

Location

MeSH Terms

Interventions

Surgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 17, 2011

First Posted

August 22, 2011

Study Start

January 1, 2013

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

December 15, 2022

Record last verified: 2022-12

Locations